UCI study finds effective colon cancer prevention treatment

Courtesy EurekAlert! - Cancer  Sun, 04/13/2008 - 23:00

Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.


 

More related items

Low-dose DFMO reduces colon cancer risk without toxicity
A combination of the targeted agent difluoromethylornithine (DFMO) at a low dose and sulindac, a nonsteroidal anti-inflammatory drug, reduces the...

How what and how much we eat (and drink) affects our risk of...
A healthy diet and lifestyle protect against a wide range of diseases, and new research presented at the American Association for Cancer Research...

Colon cancer linked to unequal gene activity
(Ohio State University) Researchers here have discovered that a subtle difference in the activity of a pair of genes may be responsible for one of...

Avalon Pharmaceuticals names lead development candidate in...
(Dorland Global Public Relations) Avalon Pharmaceuticals announces the nomination of AVN316 as a lead clinical development candidate in its...

Your Ultimate Pilates Body® Challenge: At the Gym, on the Mat,...
In this remarkable new program, Pilates instructor Brooke Siler once again revolutionizes the world of Pilates, reinventing how and where Pilates is...

Sex on the Brain: 12 Lessons to Enhance Your Love Life
What is your best tool for achieving the ultimate sexual pleasure? Your brain! Everyone wants to know how to improve his or her love life, but so few...

Carlson Laboratories - Super Omega-3, 130 softgels


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com